Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 2/20 | 0.71 |
| ▸ | CA2 | P00918 | 6/20 | 0.66 |
| ▸ | CA1 | P00915 | 4/20 | 0.66 |
| ▸ | TSHR | P16473 | 2/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.55 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.55 |
| ▸ | MMP2 | P08253 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | RRM1 | P23921 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11692574 | 0.98 | USP2 (0.69) | USP2CA2CA1TSHRMAPK1 | |
| SCHEMBL22414705 | 0.94 | USP2 (0.69) | USP2CA2CA1TSHRMAPK1 | |
| SCHEMBL23140154 | 0.92 | USP2 (0.61) | USP2CA2CA1TSHRMAPK1 | |
| SCHEMBL18541163 | 0.92 | USP2 (0.66) | USP2CA2CA1TSHRMAPK1 | |
| SCHEMBL16390491 | 0.91 | USP2 (0.65) | USP2CA2CA1TSHRMAPK1 | |
| SCHEMBL13296411 | 0.90 | USP2 (0.74) | USP2CA2CA1TSHRDPP7 | |
| SCHEMBL16342174 | 0.89 | USP2 (0.62) | USP2CA2CA1TSHRMAPK1 | |
| SCHEMBL18664494 | 0.89 | USP2 (0.62) | USP2CA2CA1TSHRMAPK1 | |
| SCHEMBL3117146 | 0.87 | USP2 (0.60) | USP2CA2CA1TSHRMAPK1 | |
| SCHEMBL17624932 | 0.86 | USP2 (0.59) | USP2CA2CA1TSHRDPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107619950-B | Extraction composition, extraction system and application thereof | 中国科学院上海有机化学研究所 | 2021-04-20 | — | — | CN | claimed |
| CN-111749022-A | Low-foam high-concentration scouring agent and preparation method thereof | 淄博鲁瑞精细化工有限公司 | 2020-10-09 | — | — | CN | claimed |
| CN-107851470-B | Method for treating aqueous nitric acid solution resulting from dissolution of spent nuclear fuel | 原子能和替代能源委员会 | 2020-07-28 | — | — | CN | claimed |
| CN-110312702-B | Asymmetric N, N-dialkylamides, in particular for separating uranium (VI) and plutonium (IV), their synthesis and use | 原子能和替代能源委员会 | 2022-10-14 | — | — | CN | disclosed |
| CN-111749022-A | Low-foam high-concentration scouring agent and preparation method thereof | 淄博鲁瑞精细化工有限公司 | 2020-10-09 | — | — | CN | disclosed |
| CN-107851470-B | Method for treating aqueous nitric acid solution resulting from dissolution of spent nuclear fuel | 原子能和替代能源委员会 | 2020-07-28 | — | — | CN | disclosed |
| CN-107922314-B | Novel asymmetric N, N-dialkyl amide and synthetic method and application thereof | 欧安诺循环 | 2020-07-07 | — | — | CN | disclosed |
| US-7199101-B2 | Gelling agent for oil | AJINOMOTO CO., INC. (JP) | 2007-04-03 | — | — | US | disclosed |
| US-20050100572-A1 | Gelling agent for oil | AJINOMOTO CO., INC. (JP) | 2005-05-12 | — | — | US | disclosed |
| US-4011180-A | NOVEL COCATALYST SYSTEM FOR TRIMERIZING POLYISOCYANATES | THE UPJOHN COMPANY (US) | 1977-03-08 | — | — | US | disclosed |
| US-4003859-A | CATALYST OF AN AMINE, AMIDE SALT AND DIBUTYL TIN(ALKANOATE) | THE UPJOHN COMPANY (US) | 1977-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050100572-A1 | Gelling agent for oil | FASN, NR1H3, CCNB2 | USP2 2558/4885CA2 4627/4885CA1 4374/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.